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Joe Z. Tsien,* Dong Feng Chen,* may lead to severe developmental defects or premature
death (for a review, see Joyner, 1994), which can pre-David Gerber,* Cindy Tom,* Eric H. Mercer,†
clude analysis of postdevelopmental gene functions. IfDavid J. Anderson,† Mark Mayford,‡
mutant mice do complete development, interpretationEric R. Kandel,‡ and Susumu Tonegawa*
of the experimental results often runs into two types of*Howard Hughes Medical Institute
difficulties. First, global gene knockout makes it difficultCenter for Learning and Memory
to attribute abnormal phenotypes to a particular type ofCenter for Cancer Research
cells or tissues. Second, it is often difficult to excludeDepartment of Biology
the possibility that the abnormal phenotype observedMassachusetts Institute of Technology
in adult animals arises indirectly from a developmentalCambridge, Massachusetts 02139
defect.†Howard Hughes Medical Institute
To augment the utility of gene knockout technology,Division of Biology
it is important to develop techniques that impose re-California Institute of Technology
gional or temporal restrictions, or both, to genetic dele-Pasadena, California 91125
tion. One method to accomplish cell type– or tissue‡Howard Hughes Medical Institute
type–restricted gene knockout is to exploit the Cre/loxPCenter for Neurobiology and Behavior
system, a phage P1–derived site-specific recombinationColumbia University
system in which the Cre recombinase catalyzes recom-New York, New York 10032
bination between 34 bp loxP recognition sequences
(Sauer and Henderson, 1988). The loxP sequences can
be inserted into the genome of embryonic stem cells by
homologous recombination such that they flank one or
Summary more exons of a gene of interest (called a “floxed gene”).
Of course it is crucial that the insertions do not interfere
Using the phage P1–derived Cre/loxP recombination with normal expression of the gene. Mice homozygous
system, we have developed a method to create mice for the floxed gene are generated from these embryonic
in which the deletion (knockout) of virtually any gene stem cells by conventional techniques and are crossed
of interest is restricted to a subregion or a specific to a second mouse that harbors a Cre transgene under
cell type in the brain such as the pyramidal cells of the control of a tissue type– or cell type–specific tran-
thehippocampal CA1 region. The Cre/loxP recombina- scriptional promoter. In progeny that are homozygous
tion–based gene deletion appears to require a certain for the floxed gene and that carry the Cre transgene,
level of Cre protein expression. The brain subregional the floxed gene will be deleted by Cre/loxP recombina-
restricted gene knockout should allow a more precise tion but only in those cell type(s) in which the Cre gene–
associated promoter is active (Figure 1A).analysis of the impact of a gene mutation on animal
Previously, mice containing T cell–restricted genebehaviors.
knockout were generated based on the above principles
(Gu et al., 1994). The goal of the present study was to
create mice in which Cre/loxP-mediated recombinationIntroduction
is restricted to specific regional or neuronal types. Sev-
eral factors make this task particularly challenging. First,Gene targeting in embryonic stem cells allows the pro-
most neurons in the mammalian brain enter the postmi-duction of mice containing a deletion in a predefined
totic state relatively early during development and re-gene of interest, which is called gene knockout technol-
main in that state throughout life, yet it isunclear whetherogy (Capecchi, 1989). This is a powerful technique for
Cre/loxP recombination can occur effectively in postmi-the functional identification of the gene product and
totic cells. Second, mammalian neurons with similar cy-has been widely used in biology and basic medicine
toarchitecture (e.g., pyramidal cells) are often organized(Capecchi, 1994). In the field of neuroscience, gene
into similar structures in functionally distinct regions of
knockout technology has been particularly useful in un-
the brain (e.g., CA1 versus CA3 regionsof the hippocam-
covering molecular and cellular basesof behaviors (Silva pus, or primary visual cortex versus somatosensory cor-
et al., 1992a; Silva et al., 1992b; Grant et al., 1992). tex). Thus, thequestion arises as towhether it ispossible
For instance, mice deficient in a-calcium-calmodulin– to knock out a gene differentially in these anatomically
dependent kinase II (aCaMKII) displayed impairments indistinguishable but functionally distinct regions of the
both in the induction of long-term potentiation at hippo- brain.
campal synapses (Silva et al., 1992a;) and in the acquisi- In our initial attempt to develop brain subregion- or
tion of spatial memory (Silva et al., 1992b). These results cell type–restricted gene knockout technology we used
supported the notion that synaptic strengthening under- a promoter derived from the aCaMKII gene to drive Cre
lies the formation of certain types of memory (Hebb, gene expression. An earlier study demonstrated that
1949; Eccles, 1953; Morris et al., 1986). the activity of this promoter in transgenic animals is
Conventional gene knockout techniques provide ani- restricted to the forebrain region (Mayford et al., 1995,
mals that inherit genetic deletions in all cell types. This 1996a, 1996b). We report here that efficient gene knock-
out can be accomplished in postmitotic neurons in aregionally and temporally unrestricted genetic deletion
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Figure 1. The Cre/loxP System for Gene
Knockout
(A) Strategy for cell type–restricted gene
knockout. (B) In situ detection of the Cre re-
combination by lacZ expression.
highly restricted manner within the forebrain, such as the Cre transgene, respectively, along with a nuclear
localization signal (Kalderon et al., 1984) that may pro-exclusively in CA1 pyramidal cells of the hippocampus.
mote transport of Cre recombinase to the nucleus, the
site of Cre/loxP recombination (Figure 2A).
To determine the distribution and efficiency of theResults
Cre/loxP recombination, each Cre transgenic mouse line
was crossed to a reporter mouse (Figure 1B). reporterDevelopment of a Method for Forebrain-Restricted
Gene Knockout mice were generated by incorporating a transgene in
which the chicken b-actin promoter drives the expres-Our strategy for the development of tissue- or cell type–
restricted gene knockout in the brain was composed of sion of a lacZ gene, whose transcription and translation
are prevented by a “stop” sequence (Lasko et al., 1992)two parts: first, production of Cre transgenic mouse
lines in which Cre expression is restricted to certain flanked by loxP sites. This transgene is called cAct-
XstopXlacZ (Figure 2B). Cre-mediated recombinationregions or cell types within the brain, and second, as-
sessment of the distribution and efficiency of Cre/loxP
recombination within the brain using a functional assay
(Figure 1B).
For the production of Cre transgenic mice, we chose
the 8.5 kb genomic DNA fragment derived from the
aCaMKII gene, since an earlier study indicated that ex-
pression of aCaMKII mRNA starts postnatally in the fore-
brain (Burgin et al., 1990). In addition, it has been shown
that the 8.5 kb genomic DNA fragment can confer this
regional specificity to a downstream coding sequence
under transgenic conditions (Mayford et al., 1995,
1996a, 1996b). This regional specificity of the aCaMKII
promoter was attractive because of the possibility that
it might permit a gene knockout restricted to the hippo-
campus and neocortical tissues known to play central
roles in learning and memory. Furthermore, the lack of
activity of the aCaMKII promoter during prenatal and
perinatal periods is expected to reduce the possibility
of developmental defects caused by a gene knockout Figure 2. Plasmid Constructs
during early brain development. (A) Schematic representation of a construct pJT-Cre for production
The Cre DNA construct contains an intron and an of Cre transgenic mouse. (B) Schematic representation of a con-
struct pcAct-XstopXlacZ for production of reporter mouse.SV40 polyadenylation signal at the 59 and 39 sides of
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removes the stop sequence, allowing expression of
b-galactosidase in all cell types in which the chicken
b-actin promoter is active (Figure 1B, left). In control
experiments, transgenic mice expressing a chicken
b-actin promoter-lacZ transgene exhibited b-galactosi-
dase expression in postmitotic neurons of the brain,
spinal cord, and peripheral nervous system, as well as
in the heart and some skeletal muscle (E. H. M. and
D. J. A., unpublished data). A similar pattern of b-galac-
tosidase expression was observed when reporter mice
containing the cAct-XstopXlacZ transgene were crossed
to activator mice expressing Cre under the control of
the cytomegalovirus promoter-enhancer (Zinyk et al.,
unpublished data).
In double-transgenic mice that carry the aCaMKII-Cre
transgene and the cAct-XstopXlacZ transgene, fore-
brain cells should express Cre recombinase at suffi-
ciently high levels to allow Cre/loxP recombination, re-
sulting in the deletion of the stop sequence and
expression of the lacZ gene (Figure 1B). In the remaining
regions of the brain and in other tissues, expression of
the Cre transgene should be absent or very low, so that
no Cre/loxP recombination and no expression of the
transgenic lacZ gene occur. Although the activity of the
transgenic aCaMKII promoter is restricted to the fore-
brain, the exact distribution and strength of its activity
within the forebrain can vary from one transgenic line
to another. We therefore assessed the distribution and
efficiency of Cre/loxP recombination in each Cre trans- Figure 3. Northern Blot Analysis of Cre mRNA Expression in the
genic line by crossing it with the reporter mouse and Adult Brain from Transgenic Lines
analyzing X-Gal–stained brain sections from Cre/lacZ (A) Cre mRNA expression in adult forebrain (FB) regions (cortex and
hippocampus) and hindbrain (HB) regions (cerebellum and braindouble-transgenic mice.
stem) from mouse lines T17, T29, T35, T40, T44, and T58. Twenty
micrograms of total RNA per lane was loaded and blotted. The size
of Cre mRNA is indicated at right.Generation and Characteristics of Cre
(B) Cre mRNA expression in adult cortex (CX), hippocampus (HP),
Transgenic Mice and cerebellum (CB) from brains of mouse lines T17, T29–1, and
We produced a total of 14 independent Cre transgenic T29–2. The expected 2.6 kb Cre mRNA is indicated.
founder mice by pronuclear injection of the linearized (C) Expression of Cre mRNA in the developing hippocampus of
T29–1 at P16, P19, P23, and adult (Ad). In (B) and (C) 10 mg/laneCre DNA construct. Southern blot analysis of the DNA
total RNA was loaded and blotted as described in Experimentalisolated from the offspring of the 14 founders indicated
Procedures. The same blot was reprobed with G3PDH probe as athat 11 had transmitted 1–20 copies of the Cre transgene
control for the amount of RNA loaded. G3PDH, glycerol-3-phos-
through the germline. One founder, T29, apparently had phate dehydrogenase.
two clusters of the transgene on separate chromosomes
since these clusters segregated during early breeding to
T29–1 and T29–2 sublines also expressed the normal
generate two sublines, T29–1 and T29–2, each exhibiting
2.6 kb Cre mRNA only in forebrain (data not shown). We
distinct distributions of Cre/loxP recombination (see
dissected out the cortex and hippocampus separately
below). from T17, T29–1, and T29–2 and examined each, along
The expected forebrain-restricted expression of the with the cerebellum, for Cre mRNA expression. Both
Cre transgene was tested in 9 of the 11 founder lines cortex and hippocampus of all three lines contained
by Northern blot analysis of RNA derived from two broad the 2.6 kb Cre mRNA, while it was negative or barely
subregions of the brain: the cortex and hippocampus detectable in cerebellum (Figure 3B). In T29–1 and
combined (forebrain) and the cerebellum and brain stem T29–2, the amount of the Cre mRNA was similar in cortex
combined (hindbrain) (Figure 3A). Four lines, T17, T29, and hippocampus, but in T17 it seemed to be greater
T40, and T50, (T50 data not shown) expressed the ex- in cortex than in hippocampus.
pected 2.6 kb Cre mRNA in forebrain but not in hind- Although the transcription of mRNA of CaMKII driven
brain. The fifth line, T44, expressed an abnormally large by the aCaMKII promoter has been shown to be silent
(9 kb) Cre sequence–containing mRNA in both forebrain until several days after birth (Burgin et al., 1990), when
and hindbrain. This mRNA may have originated from a most neural circuits are already formed (Pokorny and
fusion gene composed of a broadly active endogenous Yamamoto, 1981a, 1981b;Stanfield and Cowan, 1979), it
gene and the integrated Cre transgene. The remaining was still possible that the Cre transgene could somehow
four founder lines, T28, T35, T46, and T58 (data for T28 disrupt normal development of the brain. We therefore
and T46 not shown), expressed no detectable Cre examined the gross brain anatomy of the brains of sev-
eral Cre transgenic lines by Nissl staining. We found nomRNA. A subsequent experiment indicated that both
Cell
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Figure 4. Cre/loxP Recombination Patterns in the Brains from Different Cre/lacZ Transgenic Lines Determined by X-Gal Blue Staining
Sagittal brain sections of the lacZ reporter (R), T17/lacZ, T29–1/lacZ, and T29–2/lacZ mice were stained with X-Gal and then counterstained
with cresyl violet (A, C, E, G) or with eosin (B, D, F, H). In cresyl violet–stained sections, cerebellum and hippocamal neurons are heavily
stained, partially obscuring the X-Gal staining, which is restricted to different regions of the forebrain in all lines illustrated (see eosin-stained
sections). Scale bar, 1 mm.
significant difference in the organization of the various reporter mouse and analyzed sagittal brain sections of
the double- transgenic mice by X-Gal staining (Figuresbrain nuclei or in the arrangement of cell layers within
4 and 5 and data not shown). We observed that Cre/major brain nuclei in several Cre transgenic lines com-
loxP recombination, as depicted by blue cells, was re-pared to nontransgenic littermates (Figures 4 and 5). We
markably restricted to the forebrain. In T17/lacZ double-also observed no overt behavioral abnormalities in the
transgenic mice, dense staining was observed in theCre transgenic mice.
CA1 region of the hippocampus and somewhat lighter
staining in the CA3 region (Figures 4C, 4D, and 5C).
Cre/loxP-Mediated Recombination in the Forebrain Judging from the size of the cells and their location
We crossed five Cre transgenic lines or sublines (T17, within the hippocampus, most of the stained cells ap-
peared to be pyramidal cells (Figures 5C and 5D). OnlyT29–1, T29–2, T40, and T50) with the lacZ transgenic
Cell Type–Specific Gene Knockout in the Brain
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Figure 5. Distribution and Efficiency of Cre/loxP Recombination in Various Transgenic Mice Examined at Higher Magnification
(A, C, E, and G) The distribution of Cre/loxP recombination in the hippocampus of the reporter T17/lacZ, T29–1/lacZ, and T29–2/lacZ mice,
respectively, as visualized by X-Gal staining and cresyl violet counterstaining. Scale bar, 500 mm.
(B, D, F, and H) The CA1 region of the hipppocampus from the same set of mice. Scale bar, 100 mm. (I) The cortex and striatum of T29–1/
lacZ. Scale bar, 500 mm. (J) The cortex of T29–2/lacZ. Scale bar, 200 mm.
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Table 1. Efficiency of Cre/loxP Recombination Assessed by Quantification of X-Gal–Stained Cells
Dentate
Mouse Line CA1 CA3 Gyrus Cortex Striatum Cerebellum
T17/lacZ 76% 62% 8.6% 16% 4.4% 0%
(348/457) (99/159) (83/962) (97/609) (28/628)
T29-1/lacZ 98% 1.4% 0.3% 0.2% 0.5% 0%
(1126/1150) (5/368) (10/2981) (17/7500) (14/3000)
T29-2/lacZ 99.5% 43% 14% 9.4% 29% 0%
(428/430) (69/138) (129/908) (94/1000) (243/1000)
T40/lacZ 99% 0% 0.1% 0% 0% 0%
(405/409) (0/128) (1/1000) (0/1000) (0/1250)
T50/lacZ 96% 0.7% 0.3% 0.3% 0.2% 0%
(1167/1215) (3/430) (8/3028) (21/7500) (7/2900)
The numbers in parentheses indicate X-Gal–stained cells/total cells. The percentages of X-Gal–positive cells were calculated from these
numbers.
occasional cells were stained in the dentate gyrus and T29–2/lacZ double-transgenic mice (Figures 4G, 4H, 5G,
and 5H). In these mice, blue cells were observed in CA1in the cortex (Figure 5C). No stained cells were detected
in the remaining brain regions such as cerebellum, brain and CA3 pyramidal cell layers and in the dentate granular
cell layer of the hippocampus as well as in the cortexstem, and thalamus (Figures 4C and 4D).
In T29–1/lacZ double-transgenic mice the staining (Figure 5J) and striatum (Figure 5I).
We assessed the proportion of cells that had under-was highly restricted to the CA1 pyramidal cell layer
of the hippocampus (Figures 4E, 4F, 5E, and 5F). The gone the Cre/loxP recombination in each subregion of
the brain by counting the numbers of X-Gal–stained cellsfrequency of stained cells within the pyramidal cell layer
was high: virtually all cells were stained (Figures 5E and and Nissl- stained cells in brain sections that had been
treated with both dyes (Table 1). The data generally5F). This staining pattern was maintained throughout the
longitudinal axis of the hippocampus (data not shown). confirm the impressions obtained by casual inspection
of the stained sections represented in Figures 4 and 5.Remarkably, two other independently derived Cre
transgenic lines, T40 and T50, gave staining patterns We also examined possible intraline variability of
T29–1 and T50 and found no significant differences inthat were indistinguishable from that of T29–1 (data not
shown). the X-Gal staining patterns among multiple individuals
belonging to the same line.The broadest distribution of staining was observed in
Figure 6. Immunohistochemistry of Cre Protein in the Brains from wild-type, T29–1, and T29–2 Mice
(A) Hippocampus and cortex (CX) of the wild-type mice, stained with the Cre monoclonal antibody. (B) Hippocampus and cortex of T29–1.
DG, Dentate gyrus. (C) Striatum (STR) region of T29–2. (D) Hippocampus and cortex of T29–2. (E) Cerebellar (CB) region of T29–2.
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Cre Recombinase Distribution Roughly the middle of the third postnatal week, with the adult
pattern of recombination established by the fourth post-Correlates with the Distribution
of Cre/loxP Recombination natal week.
Within the forebrain the distribution of Cre mRNA, as
roughly assessed by Northern blot analysis, did not Discussion
seem to correlate well with the distribution of Cre/loxP
recombination. For instance, in T29–1 mice, Cre mRNA Our data indicate that the Cre/loxP recombination sys-
tem can be used to generate mouse strains in whichappears to be as abundant in the cortex as in the hippo-
campus (Figure 3B), whereas Cre/loxP recombination deletion in a predefined gene can be regionally and
temporally restricted in the brain. The major factor thatwas highly restricted to the CA1 pyramidal cell layer of
the hippocampus in T29–1/lacZ double-transgenic mice determines this specificity is the nature of the transcrip-
tional promoter that drives the expression of the Cre(Figures 4E, 4F, 5E, and 5F).
To identify parameters that affect the distribution of gene. In this study we used the transgenic aCaMKII
promoter shown to be specific for cells in the forebrainCre/loxP recombination, we examined the distribution
of the Cre recombinase in T29–1 and T29–2 brains by (Mayford et al., 1995, 1996a, 1996b) and presumably
active only postnatally (Burgin et al., 1990). Consistentimmunohistology using an anti-Cre monoclonal anti-
body (see Experimental Procedures) (Figure 6). In T29–1, with these characteristics of the aCaMKII promoter, we
found that Cre/loxP recombination is restricted to cellsstaining with the antibody was significantly greater in
the CA1 pyramidal cell layers than in other regions of the in the forebrain and occurs during the third postnatal
week. The fact that Cre/loxP recombination does notforebrain, including CA3 and the dentate gyrus of the
hippocampus and neocortex (Figure 6B). In contrast, in occur until the third postnatal week is advantageous.
By knocking out a gene of interest at the third postnatalT29–2, the Cre epitope was more widely spread within
the hippocampus (Figure 6D) and was clearly visible in week, one can avoid most if not all of the developmental
effects of the gene deletion, thus allowing more precisethe cortex (Figure 6D) and in the striatum (Figure 6C).
In addition, the cerebellar Purkinje cells seem to be interpretation of the gene function in adulthood.
Different Cre transgenic lines gave rise to differentstained, albeit lightly (Figure 6E). No staining was ob-
served in the control wild-type mouse sample (Fig- patterns of the Cre/loxP recombination within the fore-
brain. Such variations are not surprising since eachure 6A).
These results indicate that the frequency of Cre re- transgenic line represents a unique genomic site of inte-
gration and each locus can modify the promoter speci-combinase–positive cells correlates fairly well with the
frequency of Cre/loxP recombination–positive cells in ficity and Cre expression. However, we are somewhat
surprised at the stringency with which Cre/loxP recom-various parts of the brain, although a few exceptions
(e.g., T29–2 cerebellum) were noticed. bination is confined to CA1 pyramidal cells in several
Cre/lacZ transgenic lines (T29–1, T40, and T50 with the
Cre/loxP Recombination Occurs during the Third lacZ transgene) and at the high frequency (three of five)
with which these Cre transgenic lines were found. Al-Postnatal Week
We examined the developmental time course of Cre/ though unknown technical reasons prevented us from
determining the precise distribution of Cre mRNA by inloxP recombination in several Cre/lacZ double-transgenic
mice by subjecting brain sections from mice of varying situ hybridization, the Northern blot data suggest that
the overall content of Cre mRNA in the cortex is notages to X-Gal staining. In T17/lacZ, T29–1/lacZ, and
T29–2/lacZ mice, no X-Gal staining was observed at P16 substantially lower than that in the hippocampus in
T29–1 mice. Nevertheless, immunohistology with anti-or earlier (Figures 7A, 7D, 7H, and 7I). In T17/lacZ mice,
stained cells were first detected in the outer pyramidal Cre monoclonal antibody indicated that the recombi-
nase is more abundant in the CA1 pyramidal cell layercell layer of the CA1 region at P18 (Figure 7B). At this
stage the majority of CA1 pyramidal cells clearly were than in the rest of the hippocampus and in the cortex.
One possibility is that the aCaMKII promoter is particu-unstained. However, the staining spread to the majority
of CA1 pyramidal cells and to some CA3 cells by P23, larly active in CA1 pyramidal cells, such that the minimal
level of Cre recombinase required for the recombinationwhen the adult pattern of staining was almost estab-
lished. In T29–1/lacZ mice, we first observed the Cre is reached more frequently in these cells as opposed
to other forebrain cells. Anther possibility is that CA1recombination at P19 (Figure 7E). As the mice aged,
the recombination spread to more cells but was strictly pyramidal cells provide environmental factors that are
favorable for the synthesis, stability, transport, or activ-restricted to the CA1 pyramidal cell layer (Figures 7F
and 7G). By P29, the adult pattern of recombination was ity of the Cre recombinase.
In ourstudy, brain subregional and cell type specificityestablished (Figure 7G). In agreement with this develop-
mental course of Cre/loxP recombination, the level of of Cre/loxP recombination was determined using the
floxed stop and lacZ sequences integrated at a particu-Cre mRNA in the hippocampus of T29–1 mice was low
at P16 and P19,but substantial at P23 (Figure 3C). In lar genomic locus as the recombination substrate. Does
the integration site of the recombination substrate (i.e.,T29–2/lacZ mice, the Cre/loxP recombination was de-
tectable at P19 in a minority of cells in hippocampal loxP site) affect the regional or cell type specificity of
Cre/loxP recombination? We examined this issue byregions, in the cortex, and in the striatum (Figures 7J
and 7K). crossing T29–1 mice with mice carrying the floxed geno-
mic NMDAR1 gene. As shown in an accompanying arti-Thus, in the Cre/lacZ double-transgenic mouse lines
examined, Cre/loxP recombination was initiated during cle, NMDAR1 gene knockout appears to be restricted
Cell
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Figure 7. Developmental Time Course of Cre/loxP Recombination in Three Cre Transgenic Mice Individually Crossed to the lacZ reporter
Mice
The brain sections were stained with X-Gal and counterstained with eosin. The types and postnatal dates of the mice are indicated. (A–H and
J) The hippocampus. (I and K) The cortex and striatum. DG, dentate gyrus; CX, cortex; Str, striatum. Scale bar, 500 mm.
to CA1 pyramidal cells in progeny carrying the transgenic certain transgenic conditions (Oberdick et al., 1990). We
have been able to produce L7 promoter/Cre transgenicCre gene and floxed genomic NMDAR1 gene (Tsien et
al., 1996 [this issue of Cell]). Consequently, the pattern mouse lines that restrict Cre/loxP recombination to Pur-
kinje cells (M. Hasan and S. T., unpublished data). Aof the Cre/loxP recombination does not seem to be
affected substantially by the integration site of the sub- broader application of this technology for neuroscience
depends on the availability of transcriptional promotersstrate. Thus, the transgenic lacZ mouse appears to be
a good reporter of Cre/loxP recombination, although the that are specific for a certain region or cell type in the
brain. Several genes that exhibit regionally restrictedexact distribution of the gene knockout will need to be
confirmed using the mouse carrying the specific floxed expression within the brain have been reported (Ober-
dick et al., 1990; Wei, et al., 1991), and their associatedgene of interest.
CA1 pyramidal cells undergo neurogenesis between promoters should provide useful reagents. While it is
certain that the expression of some genes is controlledE10 and E18 (Angevine, 1965) and enter the postmitotic
state by P0. They are well differentiated by P7, with fully at the transcriptional level in brain cells and that some
genes are active only in certain tissues or cell types, itestablished synaptic connections (Pokorny and Yama-
moto, 1981a, 1981b; Stanfield and Cowan, 1979). We is not clear how numerous these genes are and how
restricted their expression patterns are. For instance, ithave found that Cre/loxP recombination occurs during
the middle or end of the third postnatal week in the CA1 would be useful to identify genes and their promoters
that are active only in a certain region of the cortex thatpyramidal cells in several Cre/lacZ mice, indicating that
this type of recombination is not inhibited by the highly shares similar anatomical features with other cortical
regions but that differs in function. In this respect, ourdifferentiated, postmitotic state of the CA1 neurons. If
other types of neurons can also accommodate postmi- finding that Cre/loxP recombination occurs efficiently in
CA1 pyramidal cells but remains undetectable in CA3totic recombination, the development of a Cre/loxP-
based inducible gene knockout technology should pyramidal cells in transgenic lines is encouraging. Sys-
tematic attempts to identify and clone differentially ac-greatly benefit neuroscientific studies (see below). This
technology will be advantageous because most ap- tive genes in the central nervous system could provide
further reagents.proaches will require the induction of a gene knockout in
an adult animal containing neurons that are in advanced Studies of molecular and cellular mechanisms under-
lying behavioral characteristics of a vertebrate animalpostmitotic states.
In the work described here the aCaMKII promoter was have traditionally been carried out using pharmacologi-
cal blockades (Morris et al., 1986; Davis and Squire,used to drive expression of the Cre transgene, but there
is no reason why other transcriptional promoters would 1984), namely by introducing a receptor antagonist or
an enzyme inhibitor into the brain and determining thenot be effective. In fact, we have recently used the L7
promoter, which has been reported to be active prefer- effect on a specific behavior. The tissue- or cell type–
restricted gene knockouts provide an alternative means.entially in the Purkinje cells of the cerebellum under
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frozen immediately in liquid nitrogen. Total RNA was purified usingWhile the two methods are complementary, genetic de-
the guanidium thiocyanate method or Tri-reagent method. Ten mi-letion is generally superior to pharmacological blockade
crograms of total mRNA was electrophoresed through agarose-with respect to molecular and anatomical specificities
formaldehyde gels, transferred onto nitrocellulose with 103 SSC
and animal-to-animal reproducibility (Davis et al., 1992; (Schleicher and Schuell). The filters were hybridized to 32P-labeled
Saucier et al., 1996). For instance, while many antago- Cre probe or G3PDH probe (Clonetech) in a quick hybridization
solution (Stratagene) according to the provided manuals andnists cannot distinguish receptor isoforms, genetic
washed under high stringency conditions (twice for 5 min each inblockade can make that distinction. Likewise, while it
23 SSC at room temperature and three times for 15 min each inis difficult to target a drug with the same concentration
0.13 SSC at 658C). The filters were exposed to films or Intensifyingreproducibly to a specific area of the brain, or especially
Plate screens (Fuji).
to a specific cell type, a genetic blockade can be highly
confined and reproducible, as evidenced by the T29–1 Histology
line. The brains from transgenic and wild-type mice at various age were
perfused with ice-cold PBS buffer and 30% sucrose, dissected, andOne limitation of the genetic technology available now
rapidly frozen in mounting medium. Cryostat sections (15–20 mm)is the lack of a temporal control. However, temporal
were prepared and postfixed for 5 min in 4% paraformaldehyde inrestrictions can be added to the cell type–restricted
PBS buffer (pH 7.5). The fixed sections were washed twice with PBS
knockout technology by combining it with, for instance, and subjected to X-Gal staining overnight for up to 20 hr at room
the recently reported gene induction system based on temperature. The X-Gal staining solution contains 1 mg/ml X-Gal
the tetracycline repressor/operator system or other in- (4-chloro-5-bromo-3-indolyl-b-galactosidase), 4 mM K4Fe(CN)6·3H2O,
4 mM K3Fe(CN)6, and 2 mM MgCl2 in PBS. The X-Gal–stained slidesducible system (Kistner et al., 1996; Zhang et al., 1996;
were washed with PBS twice and once in distilled water and thenWang et al., 1994).
counterstained with eosin or cresyl violet (Nissl staining). Light mi-




Estimation of Cre/loxP Recombination EfficiencyThe Cre transgene expression vector pJT-CRE was constructed by
Brain sections (20 mm) that were double-stained by X-Gal and cresyl
inserting the 2.6 kb NotI fragment of plasmid pZQCRE into the
violet were examined under a Nikon microscope, and the number
unique NotI site of pMM279 containing a 8.5 kb CaMKII promoter
of neurons was counted. In the hippocampus, all of the neurons in
sequence (Mayford et al., 1995, 1996a, 1996b). The 2.6 kb NotI
CA1, CA3, and dentate gyrus from the slides were counted. In the
fragment of pZQCRE was composed of the Cre transgene with a
cortical area, the all the neurons in five adjacent fields (each field
nuclear localization signal (Kalderon et al., 1984) (pBS317, gift from
is 400 mm 3 400 mm) that, as a whole, covered the entire six lamina
Brian Sauer) and an exon–intron splicing and polyadenylation sig-
layers were counted. In the striatum, the neurons in five randomlynals (pNN265, a gift from Nobuki Nakanishi). The Cre transgene in
selected fields (each field is 400 mm 3 400 mm) were counted. Inexpression vector pJT-CRE was verified by DNA sequencing.
the cerebellum, we screened the whole area from each slide, and no
X-Gal– stained cells were found. The percentage of X-Gal–positiveTransgenic Mouse Production
neurons of the total number of neurons from each brain subregionThe 11.2 kb linearized DNA containing the aCaMKII promoter and
was calculated. The data were obtained with a single brain sectionthe Cre transgene was obtained by digestion of pJT-CRE with SalI
from each strain of mouse except for T29–1/lacZ and T50/lacZ,and purified away from plasmid sequence. The transgenic founders
whose data come from three brain sections, one section per animal.were produced by pronuclear injection of the linearized DNA into
BCF1 zygotes as described (Hogan et al., 1986). The Cre founders
Immunohistochemistrywere back-crossed into the B6 background for production of
For immunohistochemical analysis of the Cre transgenic and wild-transgenic offspring. The Cre transgenic mice from lines T17, T29–1,
type mice, the brains were perfused with cold PBS and then with 4%T29–2, T40, and T50 were also crossed with the Cre recombination-
paraformaldehyde. The brains were dissected out and submerged inreporter mice that carry a transgene containing a chicken b-actin
30% sucrose at 48C for 2 days before cryostat sectioning (20 mm).promoter–loxP–stop sequence–loxP–lacZ gene. The lacZ gene
The Cre antibody (catalog number MMS106P, Berkeley Antibody)bears a nuclear localization signal at its 59 end (Zinyk et al., unpub-
was applied to slides at a dilution of 1:100 and incubated at roomlished data).
temperature over night or for a week at 48C before application of
the secondary antibody (fluorescein isothiocyanate, Vector) ac-Genotyping of Transgenic Mice
cording to the instructions of the manufacturer. Fluorescence mi-The genotypes of all offspring were analyzed by Southern blot or
croscopy was performed at 103 magnification with a Nikon micro-polymerase chain reaction. For analysis by polymerase chain reac-
scope, and the images were collected with a computerized camera.tion, mouse tail DNAs (about 1 mg) were amplified 30 cycles (1 min,
948C ; 45 seconds, 558C; and 1 min, 728C) on a thermal cycler. The
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Institutes of Health grant NS32925 and by gifts from the Shionogito Sambrook et al. (1989). A 0.8 kb BamHI fragment of pBS317 was
Institute for Medical Science and Amgen, Inc. (all to S.T.).used as a hybridization probe. Hybridization was at 658C overnight
in a solution containing 10% dextran sulfate, 63 SSC, 1% SDS, and
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